Anavex Life Sciences Corp. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Anavex Life Sciences Corp. (AVXL) holds an ST Score of 61.5 out of 100 (B), with its strongest factor being Financial Strength (A+) and its weakest Momentum (D-). Analysts rate AVXL Buy across 13 ratings with a $11.00 average price target (+3.6% vs the current $2.40).
- Strongest
- Financial StrengthA+
- Weakest
- MomentumD-
All factor grades
- Financial StrengthA+
- SentimentA+
- ValuationA
- ForecastA
- ProfitabilityA-
- GrowthC-
- MomentumD-
- Piotroski1/9
Contact
AVXL stock: frequently asked questions
What is AVXL's ST Score?
Anavex Life Sciences Corp. (AVXL) has an ST Score of 61.5 out of 100, an overall grade of B. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is AVXL a buy, sell, or hold?
Wall Street's consensus rating on AVXL is Buy based on 13 analyst ratings. Our own ST Score grades it B (61.5/100). This is data, not investment advice — always do your own research.
What is AVXL's valuation grade?
Anavex Life Sciences Corp. (AVXL) earns a valuation grade of A, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is AVXL's growth grade?
Anavex Life Sciences Corp. (AVXL) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is AVXL's profitability grade?
Anavex Life Sciences Corp. (AVXL) earns a profitability grade of A-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is AVXL's financial strength grade?
Anavex Life Sciences Corp. (AVXL) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for AVXL?
The average analyst price target for Anavex Life Sciences Corp. (AVXL) is $11.00 from 13 analysts, which is +3.6% versus the recent price of $2.40.
What is AVXL's Piotroski score?
Anavex Life Sciences Corp. (AVXL) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.